Quantcast

Daily Archives: February 2, 2007

Is Options Back-Dating Good For Shareholders

Posted: February 2, 2007 at 6:58 am

According to The Wall Street Journal, Gartmore Small Cap Fund has risen about 30% in the last year, due, in part, in buying shares depressed by the options back-dating scandals. ...
Read Full Story »

Micheal Dell’s One Day Honeymoon

Posted: February 2, 2007 at 6:46 am

Michael Dell has not even had the time to put the CEO title on his business cards and he is greeted with a shareholder suit that alleged funny accounting between ...
Read Full Story »

Microsoft’s China Problem

Posted: February 2, 2007 at 6:33 am

Mozilla.org, which makes the Firefox browser that competes with Microsoft's Internet Explorer, will open a China office in the hopes of fighting Microsoft (MSFT) for share in the world's second ...
Read Full Story »

Media Digest 2/2/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Posted: February 2, 2007 at 6:24 am

According to Reuters, Mozilla, which makes the main alternative to Microsoft's (MSFT) Internet Explorer browser, is setting up an office in China to set up a fight in the world's ...
Read Full Story »

Europe Markets 2/2/2007

Posted: February 2, 2007 at 4:53 am

FTSE FTSE 100 IndexView Report04:37 AM6,312.50+30.30+0.48%.GDAXI DAXX IndexView Report04:37 AM6,864.00+12.72+0.19%.FCHI CAC 40 IndexView Report04:37 AM5,677.39+15.14+0.27%.SSMI SMI-IndexView Report04:22 AM9,236.23+18.36+0.20%Data from ReutersDouglas A. McIntyre ...
Read Full Story »

Asia Markets 2/2/2007

Posted: February 2, 2007 at 4:50 am

N225 Nikkei Stock Average 225View Report01:00 AM17,547.11+27.61+0.16%.HSI Hang Seng IndexView Report03:01 AM20,563.68+133.52+0.65%KS11 KOSPI Index04:03 AM1,413.14+30.24+2.19%SSEC Shanghai Composite Index02:16 AM2,673.21-112.22-4.03%Data from ReutersDouglas A. McIntyre ...
Read Full Story »

Why A Negative Savings Rate Isn’t All That Worrisome

Posted: February 2, 2007 at 4:32 am

By Chad Brand of The Peridot CapitalistFrom the AP:Personal Savings Rate for 2006 Drops to Negative 1 Percent, the Lowest Level in 74 Years"The Commerce Department reported Thursday that the ...
Read Full Story »

Analyzing Exxon Mobil (XOM)

Posted: February 2, 2007 at 4:24 am

By Yaser Anwar, CSC of Equity Investment IdeasEarnings, excluding onetime, non-operating items, were $9.8 billion, EPS of $1.69 per share, well above EPS estimates of The Street, which were $1.5-1.53. ...
Read Full Story »

IBM: Tough to Recruit in India

Posted: February 2, 2007 at 4:23 am

By William Trent, CFA of Stock Market BeatIt’s been a while since we first started warning that the biggest problem for Indian IT outsourcing operations would be continuing to find ...
Read Full Story »
Sp_500_average_monthly_returns

February Trends

Posted: February 2, 2007 at 4:21 am

From Ticker SenseIt looks like the "First Day of the Month" bullish bias trumped the bearish implications of the month of February, as the S&P 500 finished the day up ...
Read Full Story »

ESOARs Approved, But Will They Fly?

Posted: February 2, 2007 at 4:19 am

From AAO WeblogLast June, we saw the invention of ESOARS - Employee Stock Option Appreciation Rights - by Zions Bancorporation. Zion’s purpose in designing the securities: to provide a valuation ...
Read Full Story »

Thursday’s Top Biotech and Medical Stocks

Posted: February 2, 2007 at 4:18 am

BiotechnologySEATTLE GENETICS I [SGEN] +15.33% GILEAD SCIENCES [GILD] +11.21% CHELSEA THERAPEUTICS [CHTP] +11.01% SGX PHARMACEUTICALS [SGXP] +9.41% IDM PHARMA INC [IDMI] +9.39% Diagnostic SubstancesRG GLBL LIFESTYLS [RGBL.OB] +12.50% SYNOVICS PHARMACEUTL ...
Read Full Story »

Hollis-Eden Anti-Radiation Government Contract Delayed Again

Posted: February 2, 2007 at 4:16 am

by Andrew VainoAccording to Greek mythology, after displeasing the gods, Sisyphus was consigned to spend eternity rolling a heavy stone up a steep hill and then watching as it rolled ...
Read Full Story »

Allos Therapeutics Announces $50.5M Financing Deal

Posted: February 2, 2007 at 4:14 am

by Adam RubensteinLot’s of action transpiring at Allos Therapeutics (ALTH) since Paul Berns has taken over the reigns. We should expect a $50.5M financing to close tomorrow courtesy of Merrill, ...
Read Full Story »